Dishman Pharmaceuticals & Chemicals Ltd.
NSE: DISHMAN | BSE: 532526
₹301.20
₹7.95
(2.71%)
As on 29-May-2017IST
Market cap
₹4,859 Cr
Revenue (TTM)
₹1,672 Cr
P/E Ratio
30.1
P/B Ratio
1
Div. Yield
0.4 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹161 Cr
-
ROE
12.8 %
-
ROCE
14.4 %
-
Industry P/E
41.23
-
EV/EBITDA
12.4
-
Debt to Equity
0.7
-
Book Value
₹--
-
EPS
₹10
-
Face value
2
-
Shares outstanding
161,394,272
10 Years Aggregate
CFO
₹1,964.44 Cr
EBITDA
₹2,503.24 Cr
Net Profit
₹1,115.59 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dishman Pharma & Chem
| 39.2 | -3.0 | 33.1 | 96.5 | 89.5 | 62.4 | 9.5 |
|
BSE Sensex*
| -7.0 | 1.3 | 2.3 | -2.4 | 6.2 | 7.6 | 10.9 |
|
BSE Healthcare#
| 17.7 | 2.0 | 12.7 | 15.7 | 22.4 | 14.1 | 12.1 |
|
Company
|
2016
|
2015
|
2014
|
|---|---|---|---|
|
Dishman Pharma & Chem
| 28.3 | 147.6 | 30.3 |
|
BSE Sensex
| 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dishman Pharma & Chem
|
301.2 | 4,858.8 | 1,672.5 | 162.1 | 15.5 | 5 | 30.1 | 1.0 |
| 3,263.8 | 26,684.7 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.1 | 15.4 | |
| 829.3 | 16,131.0 | 7,784.0 | 688.5 | 10.6 | 14 | 23.3 | 2.8 | |
| 439.3 | 16,731.0 | 2,141.5 | 58.5 | 5.8 | 3.3 | 157.5 | 4.3 | |
| 839.2 | 20,977.3 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.7 | 4.3 | |
| 914.7 | 16,425.3 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.6 | 1.8 | |
| 1,546.6 | 17,672.2 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 208.6 | 27,798.6 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,512.5 | 25,326.4 | 1,754.0 | 246.7 | -- | 27.8 | 102.6 | 20.1 | |
| 1,977.7 | 32,441.6 | 3,373.0 | 199.0 | 12.6 | 4.3 | 152.3 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Dishman Pharma & Chem
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1983
-
Chairman
Janmejay R Vyas
-
Managing Director
Arpit J Vyas
-
Group
Dishman Pharma
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Dishman Pharmaceuticals & Chemicals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsAnalyst / Investor Meet - Outcome
13-Sep-2017AGM On September 28,2017 (Thursday)
19-Aug-2017Analyst / Investor Meet ? Intimation
14-Aug-2017Analyst / Investor Meet ? Intimation
11-Aug-2017No News & Announcements are available.
FAQs for Dishman Pharma & Chem
What is the current share price of Dishman Pharmaceuticals & Chemicals Ltd Today?
The share price of Dishman Pharmaceuticals & Chemicals Ltd is ₹301.20 (NSE) and ₹301.05 (BSE) as of 29-May-2017 IST. Dishman Pharmaceuticals & Chemicals Ltd has given a return of 89.48% in the last 3 years.
What is the current PB & PE ratio of Dishman Pharmaceuticals & Chemicals Ltd?
The P/E ratio of Dishman Pharmaceuticals & Chemicals Ltd is 30.15 times as on 29-May-2017, a 27 discount to its peers’ median range of 41.23 times.
The P/B ratio of Dishman Pharmaceuticals & Chemicals Ltd is 1.01 times as on 29-May-2017, a 76 discount to its peers’ median range of 4.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2016
|
7.92
|
1.87
|
|
2015
|
5.62
|
1.09
|
|
2014
|
3.09
|
0.58
|
|
2013
|
2.78
|
0.54
|
|
2012
|
3.26
|
0.40
|
What is the 52 Week High and Low of Dishman Pharmaceuticals & Chemicals Ltd?
The 52-week high and low of Dishman Pharmaceuticals & Chemicals Ltd are Rs -- and Rs -- as of 06-Aug-2026.
What is the market cap of Dishman Pharmaceuticals & Chemicals Ltd?
Dishman Pharmaceuticals & Chemicals Ltd has a market capitalisation of ₹ 4,859 Cr as on 29-May-2017. As per SEBI classification, it is a company.
Should I invest in Dishman Pharmaceuticals & Chemicals Ltd?
Before investing in Dishman Pharmaceuticals & Chemicals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.